Related to this topic: | UK GuidelinesEquipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Post-partum Haemorrhage (PPH)
This is excessive bleeding following delivery and is described as primary and secondary.
The WHO definitions:
|
Aetiology
The commonest cause of PPH is uterine atony.
Other common causes are:
- Retained placenta or fragments of placenta
- Vulvar or vaginal lacerations or haematoma
Atony and retained placenta are 80% of all cases, lacerations comprise the bulk of the other 20%.
Cervical lacerations, uterine rupture, broad ligament haematoma and extra genital bleeding also need to be excluded.
Epidemiology
Most studies quote an incidence of around 5%,1 but a figure of 12% of vaginal deliveries was recorded in one Australian tertiary referral hospital.2
Risk factors
- Factors relating to the pregnancy:
- Antepartum haemorrhage in this pregnancy
- Placenta praevia (15x risk)
- Multiple pregnancy (5x risk)
- Pre-eclampsia or pregnancy induced hypertension (4x risk)
- Nulliparity (3x risk)
- Previous PPH (3x risk)
- Asian ethnic origin (2x risk)
- Maternal obesity (2x risk)
- Factors relating to delivery:
- Emergency Caesarean section (9x risk)3
- Elective CS (4x risk) - especially if >3 repeat procedures4
- Retained placenta (5x risk)
- Mediolateral episiotomy (5x risk)
- Operative vaginal delivery (2x risk)
- Labour of >12 hours (2x risk)
- >4kg baby (2x risk)
- Maternal pyrexia in labour (2x risk)
- Pre-existing maternal haemorrhagic conditions:
- Factor 8 deficiency - Haemophilia A carrier
- Factor 9 deficiency - Haemophilia B carrier
- Von Willebrands disease
Presentation
- Symptoms: Continuous bleeding, which fails to stop after delivery of placenta - third stage
- Signs: Loss of >1000ml may be accompanied by clinically apparent shock i.e. tachycardia, hypotension
Investigations
- Thorough examination of the lower genital tract. This may require theatre/anaesthesia.
- FBC, Clotting screen, Cross match
- Hourly urine output
- Continuous pulse/BP or CVP monitoring
- ECG, pulse oximetry
Associated diseases
HELLP (Haemolysis, Elevated Liver enzymes and Low platelets)
Management
Non-drug
Ideally one of the emergency drills to be practised by the team on labour ward, along with shoulder dystocia.
- Calling and alerting expert assistance. If the perceived blood loss is 500-1000ml and there are no signs of clinical shock, basic measures, (cross match 2 units, FBC, Clotting screen, IV access and monitoring clinical observations ) should suffice.
- However loss of greater than 1000mls or any signs of shock should lead to full alert of the clinical team: experienced midwife, obstetric registrar, (alert consultant), anaesthetic registrar (alert consultant), alert haematologist, alert transfusion service, call porters for transport of specimens and blood products.
Drugs
- Oxygen should be given by mask at 8 litres per minute.
- Transfuse cross matched blood (6 units initially) a.s.a.p.
- Until then infuse crystalloid or colloid as required.
- If 3.5 litres given and no blood available, give O NEG, or uncross matched blood of own blood group.
- Use a warming device and a pressure cuff.
- Do not use a blood filter.
- Do not use dextrans.
- Give up to 1 litre of FFP and 10 units of cryoprecipitate if clinically indicated.
A new haemostatic agent- recombinant Factor VII a - has had some clinical success, but its efficacy and safety is untested in clinical trials as yet.5,6
Surgical
- Secure IV access with 2 x14 gauge cannulae
- Stop the bleeding
- Exclude other causes than atony
- Ensure bladder empty and bi-manually compress the uterus ±rub up a contraction. A Sengstaken-Blakemore tube has been used to compress the uterus. One series of 17 cases showed a 71% success rate in stopping the haemorrhage.7
- Give IV syntocinon 10 units or IV ergometrine 500 mcg
- Commence syntocinon infusion 30 units in 500ml
- IM Carboprost 500mcg
- Resort to surgery early. At laparotomy inject carboprost directly into the myometrium.
- Bilateral ligation of the uterine arteries or bilateral ligation of the internal iliac (hypogastric) arteries.
- An alternative to ligation is embolisation with gelatine sponge.8 Amenorrhoea has been reported following this, secondary to necrosis of the uterine wall and obliteration of the cavity.9
- Uterine Bracing suture, (the B-Lynch suture) to anterior and posterior uterine walls has been shown to be effective and safe,10 with reports of successful pregnancy following its use.11,12
- Hysterectomy should be considered early, especially in cases of placenta accreta or uterine rupture.
Complications
- Shock
- Collapse
- Disseminated Intravascular Coagulation
Prognosis
The Confidential Enquiry into Maternal Deaths for 2000-2002 reported 17 deaths related to obstetric haemorrhage in that triennium.13 This gives a rate of 8.5 per million.
Prevention
The Active Management of the Third stage of Labour; prophylactic oxytocics should be routinely used in the third stage of labour as they decrease the risk of PPH by 60%.14 For most women syntometrine ( ergometrine 0.5mg with 5i.u oxytocin) is the drug of choice. Oxytocin alone (10i.u) is preferred by some clinicians in women with hypertension.
This commonly presents in primary care as prolonged or excessive bleeding once the woman has returned home after delivery.
Aetiology
The two commonest causes are:
- Infection- endometritis. Occurs in 1-3% after spontaneous vaginal delivery. It is the most common cause of postnatal morbidity between day 2 and day 10.
- Retained products of conception (RPOC)
Endometritis risk factors
Caesarean section, prolonged rupture of membranes, severe meconium staining in liquor,15 long labour with multiple examinations, manual removal of placenta,16 mothers age at extremes of reproductive span, low socio-economic status, maternal anaemia, prolonged surgery, internal fetal monitoring and general anaesthetic.
Assessment
History: As above, also extended labour, difficult 3rd stage, ragged placenta, primary PPH.
Examination: Systemic illness, fever, rigors, tachycardia, tissue visible within loss. Suprapubic area may be tender, with elevated fundus that feels boggy in RPOC.
Investigation
- FBC
- Blood cultures are positive in 10-30%
- Check MSU
- High vaginal swab, also gonorrhoea/chlamydia
- Ultrasound; may be used if RPOC suspected, although there may be difficulty distinguishing between clot and products. RPOC are unlikely if a normal endometrial stripe is seen.
Management
- Speculum examination will allow visualisation of cervix and lower genital tract to exclude lacerations. If clot is visible within the cervical os, it may be removed with tissue forceps (though few GP regularly carry these), allowing the cervix to close.
- If infection suspected, combinations of broad spectrum e.g. amoxicillin, gentamicin and metronidazole, can be given.17 Patient may need to be referred if too unwell to tolerate oral medication; IV clindamycin and gentamicin tds until afebrile for greater than 24 hours.18 Oral follow up treatment is not required. Use doxycyline if chlamydia is suspected.
- If retained products of conception are suspected elective curettage with antibiotic cover may be required.
- Patient may require iron supplementation if Hb has fallen. Warn of the risk of constipation.
Prognosis
90% of cases treated with antibiotics improve within 48-72 hours. If this is not the case, the patient should be re-evaluated.
Document references
- Magann EF, Evans S, Hutchinson M, et al; Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J. 2005 Apr;98(4):419-22. [abstract]
- Henry A, Birch MR, Sullivan EA, et al; Primary postpartum haemorrhage in an Australian tertiary hospital: a case-control study. Aust N Z J Obstet Gynaecol. 2005 Jun;45(3):233-6. [abstract]
- Magann EF, Evans S, Hutchinson M, et al; Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. South Med J. 2005 Jul;98(7):681-5. [abstract]
- Silver RM, Landon MB, Rouse DJ, et al; Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006 Jun;107(6):1226-32. [abstract]
- Bouwmeester FW, Jonkhoff AR, Verheijen RH, et al; Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol. 2003 Jun;101(6):1174-6. [abstract]
- Verre M, Bossio F, Mammone A, et al; Use of recombinant activated factor VII in a case of severe postpartum haemorrhage. Minerva Ginecol. 2006 Feb;58(1):81-4. [abstract]
- Seror J, Allouche C, Elhaik S; Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: a series of 17 cases. Acta Obstet Gynecol Scand. 2005 Jul;84(7):660-4. [abstract]
- Pelage JP, Le Dref O, Mateo J, et al; Life-threatening primary postpartum hemorrhage: treatment with emergency selective arterial embolization. Radiology. 1998 Aug;208(2):359-62. [abstract]
- Chitrit Y, Zafy S, Pelage JP, et al; Amenorrhea due to partial uterine necrosis after uterine artery embolization for control of refractory postpartum hemorrhage. Eur J Obstet Gynecol Reprod Biol. 2006 Jul;127(1):140-2. Epub 2005 Jul 15. [abstract]
- Price N, B-Lynch C; Technical description of the B-Lynch brace suture for treatment of massive postpartum hemorrhage and review of published cases. Int J Fertil Womens Med. 2005 Jul-Aug;50(4):148-63. [abstract]
- Api M, Api O, Yayla M; Fertility after B-Lynch suture and hypogastric artery ligation. Fertil Steril. 2005 Aug;84(2):509. [abstract]
- Habek D, Vranjes M, Bobic Vukovic M, et al; Successful term pregnancy after B-Lynch compression suture in a previous pregnancy on account of massive primary postpartum hemorrhage. Fetal Diagn Ther. 2006;21(5):475-6. [abstract]
- CEMACH - Why mothers die; Confidential enquiry into maternal deaths in the UKConfidential Enquiry into Maternal and Child Health (CEMACH) - Executive Summary; (2000-2002).
- Soriano D, Dulitzki M, Schiff E, et al; A prospective cohort study of oxytocin plus ergometrine compared with oxytocin alone for prevention of postpartum haemorrhage. Br J Obstet Gynaecol. 1996 Nov;103(11):1068-73. [abstract]
- Tran SH, Caughey AB, Musci TJ; Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol. 2003 Sep;189(3):746-50. [abstract]
- Dehbashi S, Honarvar M, Fardi FH; Manual removal or spontaneous placental delivery and postcesarean endometritis and bleeding. Int J Gynaecol Obstet. 2004 Jul;86(1):12-5. [abstract]
- French L; Prevention and treatment of postpartum endometritis. Curr Womens Health Rep. 2003 Aug;3(4):274-9. [abstract]
- French LM, Smaill FM; Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001067. [abstract]
Internet and further reading
- NHS. Scotland. Guidelines for The Management of Severe Obstetric Haemorrhage (Incorporating APH and PPH); October 2004
- Wainscott MP; Pregnancy, Postpartum Hemorrhage. eMedicine, May 2006.
DocID: 2644
Document Version: 23
DocRef: bgp261
Last Updated: 13 Nov 2007
Review Date: 12 Nov 2009
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Postpartum Haemorrhage' (6 there)UK guidelines related to this topic (^ top of page)
Guidelines on Postpartum HaemorrhageOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
*** NEW *** Patient UK Newspaper
View current health newsMedical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>


